# Papaverine vs Heparin for Peripheral Arterial Catheter Patency in Pediatric Patients

> **NCT03894904** · PHASE4 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 100 (actual)

## Conditions studied

- Pediatrics
- Anesthesia
- Vasospasm

## Interventions

- **DRUG:** Papaverine
- **DRUG:** Heparin
- **DRUG:** Rescue papaverine, as needed

## Key facts

- **NCT ID:** NCT03894904
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-01
- **Primary completion:** 2020-10-10
- **Final completion:** 2020-10-10
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03894904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03894904, "Papaverine vs Heparin for Peripheral Arterial Catheter Patency in Pediatric Patients". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03894904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*